Through strategic collaborations with top academic institutions and health organizations, our clinical research program drives the development and validation of our triage risk stratification algorithms.
Status: Recruitment ongoing
In May 2021, we launched our largest clinical study validating aiTriage's capability in risk stratification for Major Adverse Cardiac Events (MACE). This prospective study, simply known as the aiTriage clinical study, commenced patient recruitment at 3 hospital sites - Singapore General Hospital, Changi General Hospital and Sengkang General Hospital - all public hospitals serving multitudes of diverse patients daily in Singapore.
We recognize the importance of diverse data and the universality of the chest pain triage issue, expanding the aiTriage clinical study beyond Singapore and incorporated three additional sites in South East Asia. Now as a multi-center study, this regional collaboration amplifies our research capacity and enriches our data with patient demographics that span across different healthcare systems and practices.
Status: Recruitment ongoing
The results of this trial could significantly impact how chest pain patients are managed in the Emergency Department. Should the aiTriage-enabled accelerated diagnostic protocol prove to perform up to expectations, it would signify a major leap forward in chest pain triage, potentially saving precious time, resources, and, most importantly, lives.